DRPMKB1.0: A Comprehensive Knowledge Base for an AI-Oriented Drug Repositioning Prediction Model
- 31 December 2025
- journal article
- Published by American Chemical Society (ACS) in Journal of Chemical Information and Modeling
- Vol. 66 (1) , 122-137
Abstract
Drug repositioning (DR) reduces the risks and costs of drug development by identifying new uses for approved drugs. The rapid growth of artificial intelligence (AI) has led to many computational models. However, without effective integration, excess models can waste resources and obscure valuable ones. While large language models (LLMs) are preferred for their broad applicability, integrating them with a personalized knowledge base improves task-specific accuracy. Thus, we developed the AI-oriented drug repositioning prediction model knowledge base (DRPMKB 1.0). This knowledge base compiles data from PubMed up to March 2024, covering two interfaces (display and interaction) and four dimensions (data, model, application, and reference). It includes 45 categories, 193 models, and 693 data entries, offering a comprehensive data sharing platform for DR. DRPMKB 1.0 establishes a dual-evaluation framework to standardize model selection, appraising both inherent model quality and the evidentiary support for its predictions. DRPMKB 1.0 integrates diverse data and models for personalized DR, offering tailored model recommendations based on user data, improving prediction accuracy. DRPMKB 1.0 also offers a foundation for developers to integrate models and data sets seamlessly. The knowledge base supports AI enhancement through a knowledge base for continuous model refinement.Keywords
Funding Information
- Science and Technology Department of Sichuan Province (2024YFHZ0205)
- National Natural Science Foundation of China (32270690)
This publication has 71 references indexed in Scilit:
- Aligning Large Language Models with Humans: A Comprehensive Survey of ChatGPT’s Aptitude in PharmacologyDrugs, 2024
- When large language models meet personalization: perspectives of challenges and opportunitiesWorld Wide Web, 2024
- Advancing cancer nanomedicine with machine learningActa Pharmaceutica Sinica B, 2024
- Uncovering Cell Cycle Dysregulations and Associated Mechanisms in Cancer and Neurodegenerative Disorders: A Glimpse of Hope for Repurposed DrugsMolecular Neurobiology, 2024
- Trilogy of drug repurposing for developing cancer and chemotherapy-induced heart failure co-therapy agentActa Pharmaceutica Sinica B, 2023
- Interpreting Black-Box Models: A Review on Explainable Artificial IntelligenceCognitive Computation, 2023
- MIKB: A manually curated and comprehensive knowledge base for myocardial infarctionComputational and Structural Biotechnology Journal, 2021
- DrugNet: Network-based drug–disease prioritization by integrating heterogeneous dataArtificial Intelligence in Medicine, 2015
- Treatment of Huntington's DiseaseNeurotherapeutics, 2014
- Searching protein sequence libraries: Comparison of the sensitivity and selectivity of the Smith-Waterman and FASTA algorithmsGenomics, 1991